bluebird bio, Inc. (BLUE) — Financial statements
Income statement, balance sheet, and cash flow for bluebird bio, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 84↑184.1% | 29↑720.0% | 4↓1.8% | 4↓98.5% | 251 | |
| Cost of Revenue | 89↑166.6% | 34↑232.7% | 10↓74.1% | 39↑620.1% | 5 | |
| Gross Profit | -6↓38.3% | -4↑37.8% | -6↑81.6% | -35↓114.3% | 245 | |
| Operating Expenses | ||||||
| R&D Expenses | 94↓43.8% | 168↓30.4% | 241↓24.7% | 320↑0.2% | 319 | |
| General & Administrative Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 168↑1.4% | 166↑20.9% | 137↓34.8% | 210↓12.5% | 240 | |
| Other Expenses | 3↑103.0% | -93↑30.6% | -134↓619.2% | 26↓91.8% | 316 | |
| Operating Expenses | 265↑10.3% | 240↓1.4% | 244↓56.1% | 556↓36.5% | 875 | |
| Total Costs & Expenses | 354↑29.4% | 274↑7.9% | 254↓57.3% | 595↑6.3% | 559 | |
| Operating Results | ||||||
| Operating Income | -270↓10.7% | -244↑2.4% | -250↑57.7% | -591↓5.7% | -559 | |
| Depreciation & Amortization | 61↑114.7% | 29↑241.9% | 8↑53.0% | 5↓3.1% | 6 | |
| EBITDA | -157↑6.2% | -167↑22.5% | -216↑61.3% | -557↓0.6% | -554 | |
| EBIT | -218↓11.4% | -196↑12.6% | -224↑60.4% | -565↓1.0% | -559 | |
| Interest & Other Income | ||||||
| Net Interest Income | -14↓121.5% | -6↓22.6% | -5↓701.8% | 0.88↓84.8% | 6 | |
| Interest Income | 8↓16.7% | 10↑856.3% | 1↑17.4% | 0.88↓84.8% | 6 | |
| Interest Expense | 23↑38.1% | 16↑158.7% | 6 | 0.00 | 0.00 | |
| Non-Operating Income | -52↓7.9% | -49↑60.6% | -123↓378.1% | -26 | 0.00 | |
| Other Income / Expenses | 30↓7.5% | 32↑61.4% | 20↓30.0% | 29↑2668.0% | -1 | |
| Income Before Tax | -241↓13.5% | -212↑7.9% | -230↑59.1% | -562↓0.4% | -560 | |
| Income Tax Expense | 0.07↑155.6% | -0.13↓207.7% | 0.12↓54.7% | 0.26↓62.4% | 0.69 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -241↓13.6% | -212↑8.0% | -230↑59.1% | -563↓0.3% | -561 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00↑100.0% | -257↓345.4% | -58 | |
| Net Income | -241↓13.6% | -212↑8.0% | -230↑71.9% | -819↓32.4% | -619 | |
| Bottom-Line Net Income | -241↓13.6% | -212↑8.0% | -230↑71.9% | -819↓32.4% | -619 | |
| EPS (Basic) | -24.84↓736.4% | -2.97↑12.4% | -3.39↑58.5% | -8.16↑18.0% | -9.95 | |
| EPS (Diluted) | -24.84↓736.4% | -2.97↑12.4% | -3.39↑58.5% | -8.16↑18.0% | -9.95 | |
| Weighted Average Shares | 10↓86.4% | 71↓9.2% | 79↑14.0% | 69↑10.8% | 62 | |
| Weighted Average Diluted Shares | 10↓86.4% | 71↓9.2% | 79↑14.0% | 69↑10.8% | 62 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.